<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>CurrentAnesthesia — Trauma &amp; major bleeding</title>
<subtitle>The newest Briefs placed in Trauma &amp; major bleeding.</subtitle>
<id>https://currentanesthesia.com/topics/trauma-major-bleeding/feed.xml</id>
<link rel="self" type="application/atom+xml" href="https://currentanesthesia.com/topics/trauma-major-bleeding/feed.xml"/>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/topics/trauma-major-bleeding/"/>
<updated>2026-10-28T04:49:16.800Z</updated>
<author><name>CurrentAnesthesia</name><uri>https://currentanesthesia.com/topics/trauma-major-bleeding/</uri></author>
<entry>
<title>Association Between Hemorrhage Control Interventions and Mortality in US Trauma Patients With Hemodynamically Unstable Pelvic Fractures</title>
<id>https://currentanesthesia.com/studies/association-between-hemorrhage-control-interventions-and-mortality-in-us-trauma-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/association-between-hemorrhage-control-interventions-and-mortality-in-us-trauma-2023/"/>
<published>2026-10-28T04:49:16.800Z</published>
<updated>2026-10-28T04:49:16.800Z</updated>
<summary>Cohort study · JAMA Surg, 2023. Mortality — Pelvic AE: OR 0.62 (95% CI 0.47 to 0.82); P &lt; .001; regression analysis; only pelvic AE associated with mortality reduction</summary>
</entry>
<entry>
<title>Zone 1 Endovascular Balloon Occlusion of the Aorta vs Resuscitative Thoracotomy for Patient Resuscitation After Severe Hemorrhagic Shock</title>
<id>https://currentanesthesia.com/studies/zone-1-endovascular-balloon-occlusion-of-the-aorta-vs-resuscitative-thoracotomy-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/zone-1-endovascular-balloon-occlusion-of-the-aorta-vs-resuscitative-thoracotomy-2023/"/>
<published>2026-10-28T04:49:16.800Z</published>
<updated>2026-10-28T04:49:16.800Z</updated>
<summary>Cohort study · JAMA Surg, 2023. Mortality: REBOA 44 (78.6%) · RT 52 (92.9%)</summary>
</entry>
<entry>
<title>Association Between Blood Donor Demographics and Post-injury Multiple Organ Failure after Polytrauma</title>
<id>https://currentanesthesia.com/studies/association-between-blood-donor-demographics-and-post-injury-multiple-organ-2021/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/association-between-blood-donor-demographics-and-post-injury-multiple-organ-2021/"/>
<published>2026-10-28T04:46:28.518Z</published>
<updated>2026-10-28T04:46:28.518Z</updated>
<summary>Cohort study · Ann Surg, 2021. MOF by donor sex and age: Donor-recipient sex mismatched RBC transfusions more likely associated with MOF P = 0.0012</summary>
</entry>
<entry>
<title>Burn Resuscitation Practices in North America: Results of the Acute Burn ResUscitation Multicenter Prospective Trial (ABRUPT)</title>
<id>https://currentanesthesia.com/studies/burn-resuscitation-practices-in-north-america-results-of-the-acute-burn-2021/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/burn-resuscitation-practices-in-north-america-results-of-the-acute-burn-2021/"/>
<published>2026-10-28T04:46:28.518Z</published>
<updated>2026-10-28T04:46:28.518Z</updated>
<summary>Cohort study · Ann Surg, 2021. Total fluid received, 24 hours: Albumin mean 5.2 ± 2.3 mL/kg/% TBSA burn/24 hours · Crystalloid mean 3.7 ± 1.7 mL/kg/% TBSA burn/24 hours</summary>
</entry>
<entry>
<title>Direct Trauma Center Access by Helicopter Emergency Medical Services is Associated With Improved Survival After Severe Injury</title>
<id>https://currentanesthesia.com/studies/direct-trauma-center-access-by-helicopter-emergency-medical-services-is-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/direct-trauma-center-access-by-helicopter-emergency-medical-services-is-2023/"/>
<published>2026-10-28T04:46:28.518Z</published>
<updated>2026-10-28T04:46:28.518Z</updated>
<summary>Cohort study · Ann Surg, 2023. Survival — Direct helicopter vs NTC ground + transfer: aOR for survival 2.78 (95% CI 2.24-3.44); P &lt;0.01; described as a nearly 2-fold increase in odds of survival</summary>
</entry>
<entry>
<title>Optimizing Trauma Systems: A Geospatial Analysis of the Victorian State Trauma System</title>
<id>https://currentanesthesia.com/studies/optimizing-trauma-systems-a-geospatial-analysis-of-the-victorian-state-trauma-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/optimizing-trauma-systems-a-geospatial-analysis-of-the-victorian-state-trauma-2023/"/>
<published>2026-10-28T04:46:28.518Z</published>
<updated>2026-10-28T04:46:28.518Z</updated>
<summary>Cohort study · Ann Surg, 2023. Transport directly to a major trauma service (MTS): Transported directly to an MTS (all patients, observed) 58%</summary>
</entry>
<entry>
<title>The Golden Hour of Casualty Care: Rapid Handoff to Surgical Team is Associated With Improved Survival in War-injured US Service Members</title>
<id>https://currentanesthesia.com/studies/the-golden-hour-of-casualty-care-rapid-handoff-to-surgical-team-is-associated-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/the-golden-hour-of-casualty-care-rapid-handoff-to-surgical-team-is-associated-2023/"/>
<published>2026-10-28T04:46:28.518Z</published>
<updated>2026-10-28T04:46:28.518Z</updated>
<summary>Cohort study · Ann Surg, 2023. 24-hour mortality, 24 hours — Handoff within 1 hour vs Delayed surgical care: aHR 0.34 (95% CI 0.14-0.82); P = 0.02; handoff alive to the surgical team</summary>
</entry>
<entry>
<title>Use of Bayesian Statistics to Reanalyze Data From the Pragmatic Randomized Optimal Platelet and Plasma Ratios Trial</title>
<id>https://currentanesthesia.com/studies/use-of-bayesian-statistics-to-reanalyze-data-from-the-pragmatic-randomized-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/use-of-bayesian-statistics-to-reanalyze-data-from-the-pragmatic-randomized-2023/"/>
<published>2026-10-28T04:44:26.953Z</published>
<updated>2026-10-28T04:44:26.953Z</updated>
<summary>Secondary analysis · JAMA Netw Open, 2023. Mortality, bayesian analysis — 1:1:1 vs 1:1:2: RR 0.75 (95% CrI 0.45-1.11); 24-hour mortality; 95% CrI; Bayes factor 13.7; 93% probability of superiority</summary>
</entry>
<entry>
<title>Aspirin or Low-Molecular-Weight Heparin for Thromboprophylaxis after a Fracture</title>
<id>https://currentanesthesia.com/studies/aspirin-or-low-molecular-weight-heparin-for-thromboprophylaxis-after-a-fracture-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/aspirin-or-low-molecular-weight-heparin-for-thromboprophylaxis-after-a-fracture-2023/"/>
<published>2026-10-28T04:42:32.209Z</published>
<updated>2026-10-28T04:42:32.209Z</updated>
<summary>Randomised controlled trial · N Engl J Med, 2023. Death from any cause, 90 days: Aspirin 47 (0.78%) · Low-molecular-weight heparin 45 (0.73%)</summary>
</entry>
<entry>
<title>Prehospital tranexamic acid for trauma victims</title>
<id>https://currentanesthesia.com/studies/prehospital-tranexamic-acid-for-trauma-victims-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/prehospital-tranexamic-acid-for-trauma-victims-2023/"/>
<published>2026-10-28T04:36:50.728Z</published>
<updated>2026-10-28T04:36:50.728Z</updated>
<summary>Research article · J Intensive Care, 2023. UK paramedics now authorized to give IM TXA prehospital</summary>
</entry>
<entry>
<title>Catabolism highly influences ICU-acquired hypernatremia in a mainly trauma and surgical cohort</title>
<id>https://currentanesthesia.com/studies/catabolism-highly-influences-icu-acquired-hypernatremia-in-a-mainly-trauma-and-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/catabolism-highly-influences-icu-acquired-hypernatremia-in-a-mainly-trauma-and-2023/"/>
<published>2026-10-28T04:33:02.462Z</published>
<updated>2026-10-28T04:33:02.462Z</updated>
<summary>Cohort study · J Crit Care, 2023. ICU-acquired hypernatremia: Developed ICU-acquired hypernatremia 377 (38%)</summary>
</entry>
<entry>
<title>Hemorrhage, Disseminated Intravascular Coagulopathy, and Thrombosis Complications Among Critically Ill Patients with COVID-19: An International COVID-19 Critical Care Consortium Study*</title>
<id>https://currentanesthesia.com/studies/hemorrhage-disseminated-intravascular-coagulopathy-thrombosis-complications-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/hemorrhage-disseminated-intravascular-coagulopathy-thrombosis-complications-2023/"/>
<published>2026-10-28T04:21:38.918Z</published>
<updated>2026-10-28T04:21:38.918Z</updated>
<summary>Cohort study · Crit Care Med, 2023. Prevalence of HECTOR complications: Any HECTOR complication (1,732/11,969) 14%</summary>
</entry>
<entry>
<title>Association of red blood cells and plasma transfusion versus red blood cell transfusion only with survival for treatment of major traumatic hemorrhage in prehospital setting in England: a multicenter study</title>
<id>https://currentanesthesia.com/studies/association-red-blood-cells-plasma-transfusion-red-blood-cell-transfusion-only-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/association-red-blood-cells-plasma-transfusion-red-blood-cell-transfusion-only-2023/"/>
<published>2026-10-28T04:14:48.087Z</published>
<updated>2026-10-28T04:14:48.087Z</updated>
<summary>Cohort study · Crit Care, 2023. Death, 24-h — RCP vs RBC: aOR 0.69 (95% CI 0.52; 0.92)</summary>
</entry>
<entry>
<title>Shock index as predictor of massive transfusion and mortality in patients with trauma: a systematic review and meta-analysis</title>
<id>https://currentanesthesia.com/studies/shock-index-as-predictor-of-massive-transfusion-and-mortality-in-patients-with-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/shock-index-as-predictor-of-massive-transfusion-and-mortality-in-patients-with-2023/"/>
<published>2026-10-28T04:14:48.087Z</published>
<updated>2026-10-28T04:14:48.087Z</updated>
<summary>Meta-analysis · Crit Care, 2023. MT prediction: SI: sensitivity 0.68 [0.57; 0.76]; specificity 0.84 [0.79; 0.88]; AUC 0.85 [0.81; 0.88]; LR+ 4.24 [3.18-5.65]; LR- 0.39 [0.29-0.52]</summary>
</entry>
<entry>
<title>The European guideline on management of major bleeding and coagulopathy following trauma: sixth edition</title>
<id>https://currentanesthesia.com/studies/the-european-guideline-on-management-of-major-bleeding-and-coagulopathy-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/the-european-guideline-on-management-of-major-bleeding-and-coagulopathy-2023/"/>
<published>2026-10-28T04:14:48.087Z</published>
<updated>2026-10-28T04:14:48.087Z</updated>
<summary>Guideline or statement · Crit Care, 2023.</summary>
</entry>
<entry>
<title>Comparing restrictive versus liberal oxygen strategies for trauma patients: The TRAUMOX2 trial—Statistical analysis plan</title>
<id>https://currentanesthesia.com/studies/comparing-restrictive-versus-liberal-oxygen-strategies-for-trauma-patients-the-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/comparing-restrictive-versus-liberal-oxygen-strategies-for-trauma-patients-the-2023/"/>
<published>2026-10-28T03:44:37.230Z</published>
<updated>2026-10-28T03:44:37.230Z</updated>
<summary>Trial design · Acta Anaesthesiol Scand, 2023. Composite of 30-day mortality and/or major respiratory complications (pneumonia and/or ARDS), 30 days</summary>
</entry>
<entry>
<title>Thromboembolic and bleeding events in ICU patients with COVID‐19: A nationwide, observational study</title>
<id>https://currentanesthesia.com/studies/thromboembolic-and-bleeding-events-in-icu-patients-with-covid-19-a-nationwide-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/thromboembolic-and-bleeding-events-in-icu-patients-with-covid-19-a-nationwide-2022/"/>
<published>2026-10-28T03:44:37.230Z</published>
<updated>2026-10-28T03:44:37.230Z</updated>
<summary>Cohort study · Acta Anaesthesiol Scand, 2022. Thromboembolic and bleeding events in ICU: Thromboembolic event, n % 158 (12%) (95% CI 10-13)</summary>
</entry>
<entry>
<title>Cognitive aids in the management of clinical emergencies: a systematic review</title>
<id>https://currentanesthesia.com/studies/cognitive-aids-in-the-management-of-clinical-emergencies-a-systematic-review-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/cognitive-aids-in-the-management-of-clinical-emergencies-a-systematic-review-2022/"/>
<published>2026-10-28T03:25:23.999Z</published>
<updated>2026-10-28T03:25:23.999Z</updated>
<summary>Meta-analysis · Anaesthesia, 2022. Missed care steps: Cognitive aids 11% · Usual care 43.3%</summary>
</entry>
<entry>
<title>Association of Whole Blood With Survival Among Patients Presenting With Severe Hemorrhage in US and Canadian Adult Civilian Trauma Centers</title>
<id>https://currentanesthesia.com/studies/association-of-whole-blood-with-survival-among-patients-presenting-with-severe-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/association-of-whole-blood-with-survival-among-patients-presenting-with-severe-2023/"/>
<published>2026-10-27T23:42:42.982Z</published>
<updated>2026-10-27T23:42:42.982Z</updated>
<summary>Cohort study · JAMA Surg, 2023. Mortality, 24 hours — WB-MTP vs MTP-only: HR 0.63 (95% CI 0.41-0.96); P = .03; 37% lower risk of mortality</summary>
</entry>
<entry>
<title>Clinical Practice Guideline Recommendations For Pediatric Multisystem Trauma Care: A Systematic Review</title>
<id>https://currentanesthesia.com/studies/clinical-practice-guideline-recommendations-for-pediatric-multisystem-trauma-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/clinical-practice-guideline-recommendations-for-pediatric-multisystem-trauma-2023/"/>
<published>2026-10-27T23:40:12.801Z</published>
<updated>2026-10-27T23:40:12.801Z</updated>
<summary>Meta-analysis · Ann Surg, 2023. Number, strength and evidence quality of CPG recommendations for pediatric multisystem trauma: CPGs reviewed 19</summary>
</entry>
<entry>
<title>Low Titer Group O Whole Blood In Injured Children Requiring Massive Transfusion</title>
<id>https://currentanesthesia.com/studies/low-titer-group-o-whole-blood-in-injured-children-requiring-massive-transfusion-2021/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/low-titer-group-o-whole-blood-in-injured-children-requiring-massive-transfusion-2021/"/>
<published>2026-10-27T23:40:12.801Z</published>
<updated>2026-10-27T23:40:12.801Z</updated>
<summary>Cohort study · Ann Surg, 2021. 28-day survival, 28 days — LTOWB vs CT: aOR 0.41, event not clearly stated; P = 0.02; significantly improved survival with LTOWB; adjusted for age, total blood product volume in 24 h, admission base deficit, international normalized ratio (INR), injury severity score (ISS)</summary>
</entry>
<entry>
<title>Single-nuclei RNA Profiling Reveals Disruption of Adipokine and Inflammatory Signaling in Adipose Tissue of Burn Patients</title>
<id>https://currentanesthesia.com/studies/single-nuclei-rna-profiling-reveals-disruption-of-adipokine-and-inflammatory-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/single-nuclei-rna-profiling-reveals-disruption-of-adipokine-and-inflammatory-2023/"/>
<published>2026-10-27T23:40:12.801Z</published>
<updated>2026-10-27T23:40:12.801Z</updated>
<summary>Cohort study · Ann Surg, 2023. Systemic inflammation and adrenergic stress increase IL-6 signaling, lipolysis, browning and adipokine dysfunction in adipose tissue of adult burn patients</summary>
</entry>
<entry>
<title>Comparison of Injuries Associated With Electric Scooters, Motorbikes, and Bicycles in France, 2019-2022</title>
<id>https://currentanesthesia.com/studies/comparison-of-injuries-associated-with-electric-scooters-motorbikes-and-bicycles-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/comparison-of-injuries-associated-with-electric-scooters-motorbikes-and-bicycles-2023/"/>
<published>2026-10-27T23:37:19.358Z</published>
<updated>2026-10-27T23:37:19.358Z</updated>
<summary>Cohort study · JAMA Netw Open, 2023. ISS of 16 or higher: E-scooter 102 (45.5%) · Motorbike 1557 (39.7%) · Bicycle 411 (47.3%)</summary>
</entry>
<entry>
<title>Effect of Dexmedetomidine on Posttraumatic Stress Disorder in Patients Undergoing Emergency Trauma Surgery: A Randomized Clinical Trial</title>
<id>https://currentanesthesia.com/studies/effect-of-dexmedetomidine-on-posttraumatic-stress-disorder-in-patients-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/effect-of-dexmedetomidine-on-posttraumatic-stress-disorder-in-patients-2023/"/>
<published>2026-10-27T23:37:19.358Z</published>
<updated>2026-10-27T23:37:19.358Z</updated>
<summary>Randomised controlled trial · JAMA Netw Open, 2023. Incidence of PTSD, 1 month postoperatively: Dexmedetomidine 14.1% · Normal saline 24.0%</summary>
</entry>
<entry>
<title>Efficacy and Safety of Early Administration of 4-Factor Prothrombin Complex Concentrate in Patients With Trauma at Risk of Massive Transfusion: The PROCOAG Randomized Clinical Trial</title>
<id>https://currentanesthesia.com/studies/procoag-efficacy-and-safety-of-early-administration-of-4-factor-prothrombin-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/procoag-efficacy-and-safety-of-early-administration-of-4-factor-prothrombin-2023/"/>
<published>2026-10-27T23:36:43.961Z</published>
<updated>2026-10-27T23:36:43.961Z</updated>
<summary>Randomised controlled trial · JAMA, 2023. Total 24-hour blood product consumption, 24 hours: 4F-PCC median 12 (IQR 5-19) U · Placebo median 11 (IQR 6-19) U</summary>
</entry>
<entry>
<title>Prehospital Tranexamic Acid for Severe Trauma</title>
<id>https://currentanesthesia.com/studies/prehospital-tranexamic-acid-for-severe-trauma-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/prehospital-tranexamic-acid-for-severe-trauma-2023/"/>
<published>2026-10-27T23:35:39.811Z</published>
<updated>2026-10-27T23:35:39.811Z</updated>
<summary>Randomised controlled trial · N Engl J Med, 2023. Survival with a favorable functional outcome (GOS-E level ≥5), 6 months: Tranexamic acid 307 (53.7%) · Placebo 299 (53.5%)</summary>
</entry>
<entry>
<title>Coagulopathy correlates with muscle titin injury in critically ill patients</title>
<id>https://currentanesthesia.com/studies/coagulopathy-correlates-with-muscle-titin-injury-in-critically-ill-patients-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/coagulopathy-correlates-with-muscle-titin-injury-in-critically-ill-patients-2022/"/>
<published>2026-10-27T23:28:00.394Z</published>
<updated>2026-10-27T23:28:00.394Z</updated>
<summary>Secondary analysis · J Crit Care, 2022. Mean N-titin/Cre: Mean N-titin/Cre significantly higher in the JAAM-DIC group</summary>
</entry>
<entry>
<title>Saudi Critical Care Society clinical practice guidelines on the prevention of venous thromboembolism in adults with trauma: reviewed for evidence-based integrity and endorsed by the Scandinavian Society of Anaesthesiology and Intensive Care Medicine</title>
<id>https://currentanesthesia.com/studies/saudi-critical-care-society-clinical-practice-guidelines-prevention-venous-2023-2/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/saudi-critical-care-society-clinical-practice-guidelines-prevention-venous-2023-2/"/>
<published>2026-10-27T23:25:45.237Z</published>
<updated>2026-10-27T23:25:45.237Z</updated>
<summary>Guideline or statement · Ann Intensive Care, 2023.</summary>
</entry>
<entry>
<title>The Efficacy of Glutamine Supplementation in Severe Adult Burn Patients: A Systematic Review With Trial Sequential Meta-Analysis</title>
<id>https://currentanesthesia.com/studies/the-efficacy-of-glutamine-supplementation-in-severe-adult-burn-patients-a-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/the-efficacy-of-glutamine-supplementation-in-severe-adult-burn-patients-a-2023/"/>
<published>2026-10-27T23:20:28.165Z</published>
<updated>2026-10-27T23:20:28.165Z</updated>
<summary>Meta-analysis · Crit Care Med, 2023. Overall mortality — Glutamine vs Control: RR 0.65 (95% CI 0.33-1.28); p = 0.21</summary>
</entry>
<entry>
<title>Early non-invasive ventilation and high-flow nasal oxygen therapy for preventing endotracheal intubation in hypoxemic blunt chest trauma patients: the OptiTHO randomized trial</title>
<id>https://currentanesthesia.com/studies/optitho-early-non-invasive-ventilation-and-high-flow-nasal-oxygen-therapy-for-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/optitho-early-non-invasive-ventilation-and-high-flow-nasal-oxygen-therapy-for-2023/"/>
<published>2026-10-27T23:14:23.345Z</published>
<updated>2026-10-27T23:14:23.345Z</updated>
<summary>Randomised controlled trial · Crit Care, 2023. Endotracheal intubation for delayed respiratory failure: Experimental 5 (7%) · Control 6 (8.6%)</summary>
</entry>
<entry>
<title>Thromboelastometry-guided haemostatic resuscitation in severely injured patients: a propensity score-matched study</title>
<id>https://currentanesthesia.com/studies/thromboelastometry-guided-haemostatic-resuscitation-in-severely-injured-patients-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/thromboelastometry-guided-haemostatic-resuscitation-in-severely-injured-patients-2023/"/>
<published>2026-10-27T23:14:23.345Z</published>
<updated>2026-10-27T23:14:23.345Z</updated>
<summary>Cohort study · Crit Care, 2023. Proportion alive and free of massive transfusion (MT), 24 h after injury: VHA 162 (75%) · CCT 112 (52%)</summary>
</entry>
<entry>
<title>Comprehensive analysis of coagulation factor delivery strategies in a cohort of trauma patients</title>
<id>https://currentanesthesia.com/studies/comprehensive-analysis-of-coagulation-factor-delivery-strategies-in-a-cohort-of-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/comprehensive-analysis-of-coagulation-factor-delivery-strategies-in-a-cohort-of-2022/"/>
<published>2026-10-27T22:55:35.298Z</published>
<updated>2026-10-27T22:55:35.298Z</updated>
<summary>Cohort study · Anaesth Crit Care Pain Med, 2022. Coagulation factor administration within first 24 hours: SH 93%; Fibrinogen concentrate (FC) 75% · MT 99%; FC 92%</summary>
</entry>
<entry>
<title>Continuous peripheral nerve blocks for analgesia of ventilated critically ill patients with multiple trauma: a prospective randomized study</title>
<id>https://currentanesthesia.com/studies/continuous-peripheral-nerve-blocks-for-analgesia-of-ventilated-critically-ill-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/continuous-peripheral-nerve-blocks-for-analgesia-of-ventilated-critically-ill-2022/"/>
<published>2026-10-27T22:55:35.298Z</published>
<updated>2026-10-27T22:55:35.298Z</updated>
<summary>Randomised controlled trial · Anaesth Crit Care Pain Med, 2022. Cumulative sufentanil consumption, 48h — CRA vs Control; p = 0.16; no significant difference</summary>
</entry>
<entry>
<title>Injury outcomes across Canadian trauma systems: a historical cohort study</title>
<id>https://currentanesthesia.com/studies/injury-outcomes-across-canadian-trauma-systems-a-historical-cohort-study-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/injury-outcomes-across-canadian-trauma-systems-a-historical-cohort-study-2023/"/>
<published>2026-10-27T22:52:26.060Z</published>
<updated>2026-10-27T22:52:26.060Z</updated>
<summary>Cohort study · Can J Anaesth, 2023. Patient case mix, case volumes, and risk-adjusted outcomes (mortality, ICU admission, hospital and ICU LOS): Patient distributions in level I and II TCs similar across provinces; significant differences in case mix and volumes for level III TCs</summary>
</entry>
<entry>
<title>Saudi Critical Care Society clinical practice guidelines on the prevention of venous thromboembolism in adults with trauma: Endorsement by the Scandinavian Society of Anaesthesiology and Intensive Care Medicine</title>
<id>https://currentanesthesia.com/studies/saudi-critical-care-society-clinical-practice-guidelines-prevention-venous-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/saudi-critical-care-society-clinical-practice-guidelines-prevention-venous-2023/"/>
<published>2026-10-27T22:48:29.585Z</published>
<updated>2026-10-27T22:48:29.585Z</updated>
<summary>Guideline or statement · Acta Anaesthesiol Scand, 2023.</summary>
</entry>
<entry>
<title>Prevalence of preoperative metabolic disturbances in elderly patients with hip fracture and their association with mortality – A retrospective cohort study</title>
<id>https://currentanesthesia.com/studies/prevalence-of-preoperative-metabolic-disturbances-in-elderly-patients-with-hip-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/prevalence-of-preoperative-metabolic-disturbances-in-elderly-patients-with-hip-2023/"/>
<published>2026-10-27T22:44:42.780Z</published>
<updated>2026-10-27T22:44:42.780Z</updated>
<summary>Cohort study · J Clin Anesth, 2023. 90-day mortality: Both acidosis and lactatemia 19.1% · Neither 4.4%</summary>
</entry>
<entry>
<title>The first hour of trauma reception is critical for patients with major thoracic trauma: A retrospective analysis from the TraumaRegister DGU</title>
<id>https://currentanesthesia.com/studies/the-first-hour-of-trauma-reception-is-critical-for-patients-with-major-thoracic-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/the-first-hour-of-trauma-reception-is-critical-for-patients-with-major-thoracic-2023/"/>
<published>2026-10-27T22:41:13.584Z</published>
<updated>2026-10-27T22:41:13.584Z</updated>
<summary>Cohort study · Eur J Anaesthesiol, 2023. Mortality: Mortality in major thoracic trauma 5.9%</summary>
</entry>
<entry>
<title>Association Between Profound Shock Signs and Peripheral Intravenous Access Success Rates in Trauma Patients in the Prehospital Scenario: A Retrospective Study</title>
<id>https://currentanesthesia.com/studies/association-between-profound-shock-signs-peripheral-intravenous-access-success-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/association-between-profound-shock-signs-peripheral-intravenous-access-success-2023/"/>
<published>2026-10-27T22:35:32.011Z</published>
<updated>2026-10-27T22:35:32.011Z</updated>
<summary>Cohort study · Anesth Analg, 2023. Number of attempts required for first IV access success (ordinal: 1, 2, 3 and higher, ultimate failure): Profound shock 67.8%; first attempt 67.8%; second attempt 16.7%; third and further attempts 5.6%; unsuccessful attempts 10% · Nonshock 80.8%; first attempt 80.8%; second attempt 9.4%; third and further attempts 3.8%; unsuccessful attempts 6%</summary>
</entry>
<entry>
<title>Association of Opioid Administration During General Anesthesia and Survival for Severely Injured Trauma Patients: A Preplanned Secondary Analysis of the PROPPR Study</title>
<id>https://currentanesthesia.com/studies/association-opioid-administration-during-general-anesthesia-survival-severely-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/association-opioid-administration-during-general-anesthesia-survival-severely-2023/"/>
<published>2026-10-27T22:35:32.011Z</published>
<updated>2026-10-27T22:35:32.011Z</updated>
<summary>Secondary analysis · Anesth Analg, 2023. Mortality, any opioid vs none — Opioid dose groups vs No opioid: OR 0.02-0.04 (CI 0.003-0.1); P &lt; .001; 6 hours; adjusted</summary>
</entry>
<entry>
<title>In Vitro Analysis of Platelet Adhesion, Aggregation, and Surface GP1bα Expression in Stored Refrigerated Whole Blood: A Pilot Study</title>
<id>https://currentanesthesia.com/studies/in-vitro-analysis-of-platelet-adhesion-aggregation-and-surface-gp1b-expression-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/in-vitro-analysis-of-platelet-adhesion-aggregation-and-surface-gp1b-expression-2023/"/>
<published>2026-10-27T22:35:32.011Z</published>
<updated>2026-10-27T22:35:32.011Z</updated>
<summary>Mechanistic study · Anesth Analg, 2023. Platelet adhesion and aggregation under high shear (PFA-100 adenosine diphosphate (ADP)/collagen closure time): Timepoint 1 mean 208.7 (+ 91.5) seconds · Timepoint 3 mean 390.0 (+ 148.3) seconds</summary>
</entry>
<entry>
<title>Narrative Review: Is There a Transfusion Cutoff Value After Which Nonsurvivability Is Inevitable in Trauma Patients Receiving Ultramassive Transfusion?</title>
<id>https://currentanesthesia.com/studies/narrative-review-is-there-a-transfusion-cutoff-value-after-which-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/narrative-review-is-there-a-transfusion-cutoff-value-after-which-2023/"/>
<published>2026-10-27T22:35:32.011Z</published>
<updated>2026-10-27T22:35:32.011Z</updated>
<summary>Research article · Anesth Analg, 2023. Effects of UMT on outcomes including survival; whether a threshold transfusion limit exists after which mortality is inevitable: Data on utility of UMT in trauma of poor quality; no universally accepted transfusion cutoff exists</summary>
</entry>
<entry>
<title>Study of the Relationship Between Liver Function Markers and Traumatic Rhabdomyolysis: A Retrospective Study of Hemorrhagic Patients Admitted to Intensive Care Unit in a Level I Trauma Center</title>
<id>https://currentanesthesia.com/studies/relationship-between-liver-function-markers-traumatic-rhabdomyolysis-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/relationship-between-liver-function-markers-traumatic-rhabdomyolysis-2023/"/>
<published>2026-10-27T22:35:32.011Z</published>
<updated>2026-10-27T22:35:32.011Z</updated>
<summary>Cohort study · Anesth Analg, 2023. Correlation of log-CK with liver biomarkers; liver failure: Intense RM 18.2% · No intense RM 4.6%</summary>
</entry>
<entry>
<title>Ultramassive Transfusion for Trauma in the Age of Hemostatic Resuscitation: A Retrospective Single-Center Cohort From a Large US Level-1 Trauma Center, 2011–2021</title>
<id>https://currentanesthesia.com/studies/ultramassive-transfusion-trauma-age-hemostatic-resuscitation-retrospective-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/ultramassive-transfusion-trauma-age-hemostatic-resuscitation-retrospective-2023/"/>
<published>2026-10-27T22:35:32.011Z</published>
<updated>2026-10-27T22:35:32.011Z</updated>
<summary>Cohort study · Anesth Analg, 2023. Overall mortality: Overall mortality 65% (n = 103)</summary>
</entry>
<entry>
<title>Association of Trauma Molecular Endotypes With Differential Response to Transfusion Resuscitation Strategies</title>
<id>https://currentanesthesia.com/studies/association-of-trauma-molecular-endotypes-with-differential-response-to-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/association-of-trauma-molecular-endotypes-with-differential-response-to-2023/"/>
<published>2026-10-27T18:57:44.465Z</published>
<updated>2026-10-27T18:57:44.465Z</updated>
<summary>Secondary analysis · JAMA Surg, 2023. 30-day mortality by endotype and transfusion strategy (subgroup), 30 days: TE-1 mortality with 1:1:2 28.6%</summary>
</entry>
<entry>
<title>Association of Trauma With Long-Term Risk of Death and Immune-Mediated or Cancer Disease in Same-Sex Twins</title>
<id>https://currentanesthesia.com/studies/association-of-trauma-with-long-term-risk-of-death-and-immune-mediated-or-cancer-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/association-of-trauma-with-long-term-risk-of-death-and-immune-mediated-or-cancer-2023/"/>
<published>2026-10-27T18:57:44.465Z</published>
<updated>2026-10-27T18:57:44.465Z</updated>
<summary>Cohort study · JAMA Surg, 2023. Composite of death or immune-mediated or cancer disease: Trauma 724 (32%) · Co-twin 544 (24%)</summary>
</entry>
<entry>
<title>Potential Avoidable Costs of Low-Value Clinical Practices in Acute Injury Care in an Integrated Canadian Provincial Trauma System</title>
<id>https://currentanesthesia.com/studies/potential-avoidable-costs-of-low-value-clinical-practices-in-acute-injury-care-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/potential-avoidable-costs-of-low-value-clinical-practices-in-acute-injury-care-2023/"/>
<published>2026-10-27T18:57:44.465Z</published>
<updated>2026-10-27T18:57:44.465Z</updated>
<summary>Research article · JAMA Surg, 2023. Direct health care costs associated with 11 low-value clinical practices</summary>
</entry>
<entry>
<title>Emergency Department Pediatric Readiness Among US Trauma Centers: A Machine Learning Analysis of Components Associated With Survival</title>
<id>https://currentanesthesia.com/studies/emergency-department-pediatric-readiness-among-us-trauma-centers-a-machine-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/emergency-department-pediatric-readiness-among-us-trauma-centers-a-machine-2022/"/>
<published>2026-10-27T18:55:07.732Z</published>
<updated>2026-10-27T18:55:07.732Z</updated>
<summary>Cohort study · Ann Surg, 2022. Change in survival by ED pediatric readiness component: Policy for mental health care +8.8%</summary>
</entry>
<entry>
<title>Therapeutic Interventions and Outcomes in Civilian and Military Isolated Gunshot Wounds to the Head: A Department of Defense Trauma Registry and ACS TQIP-matched Study</title>
<id>https://currentanesthesia.com/studies/therapeutic-interventions-outcomes-civilian-military-isolated-gunshot-wounds-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/therapeutic-interventions-outcomes-civilian-military-isolated-gunshot-wounds-2022/"/>
<published>2026-10-27T18:55:07.732Z</published>
<updated>2026-10-27T18:55:07.732Z</updated>
<summary>Cohort study · Ann Surg, 2022. Mortality: Military 27% · Civilian 38%</summary>
</entry>
<entry>
<title>The Restrictive Red Blood Cell Transfusion Strategy for Critically Injured Patients (RESTRIC) trial: a cluster-randomized, crossover, non-inferiority multicenter trial of restrictive transfusion in trauma</title>
<id>https://currentanesthesia.com/studies/restrictive-red-blood-cell-transfusion-strategy-critically-injured-restric-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/restrictive-red-blood-cell-transfusion-strategy-critically-injured-restric-2023/"/>
<published>2026-10-27T18:46:42.182Z</published>
<updated>2026-10-27T18:46:42.182Z</updated>
<summary>Randomised controlled trial · J Intensive Care, 2023. 28-day survival, 28 days: Restrictive 92.1% · Liberal 91.3%</summary>
</entry>
<entry>
<title>Resuscitative transesophageal echocardiography during the acute resuscitation of trauma: A retrospective observational study</title>
<id>https://currentanesthesia.com/studies/resuscitative-transesophageal-echocardiography-during-the-acute-resuscitation-of-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/resuscitative-transesophageal-echocardiography-during-the-acute-resuscitation-of-2023/"/>
<published>2026-10-27T18:44:24.801Z</published>
<updated>2026-10-27T18:44:24.801Z</updated>
<summary>Cohort study · J Crit Care, 2023. Diagnostic yield and management impact of TEE: New diagnosis made 31 (57%)</summary>
</entry>
</feed>
